Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model

DOI: 10.1080/2162402X.2017.1378843

Keywords: angiogenesis, bevacizumab, CAR T cells, immunotherapy, neuroblastoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text